US awards $1.6 billion to Novavax for COVID-19 vaccine
The US on Tuesday announced it was providing $1.6 billion in funding for the development and manufacture of a COVID-19 vaccine candidate produced by biotech firm Novavax, the largest amount awarded under Operation Warp Speed.
Jul 7, 2020
0
24